Insider Trading & Ownership of New Enterprise Associates 16, L.P.

Location
Timonium, MD
Summary
The estimated value of insider holdings of New Enterprise Associates 16, L.P. is at least $84,512,835 dollars as of 13 Feb 2026. New Enterprise Associates 16, L.P. is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $61.29M. New Enterprise Associates 16, L.P. is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $16.81M. New Enterprise Associates 16, L.P. is the 10%+ Owner of Marker Therapeutics, Inc. and owns shares of Marker Therapeutics, Inc. (MRKR) stock worth about $5.2M. New Enterprise Associates 16, L.P. is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when New Enterprise Associates 16, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of New Enterprise Associates 16, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $61,291,541 13 Jun 2023
TRVI Trevi Therapeutics, Inc. 10%+ Owner $16,814,393 31 Dec 2025
MRKR Marker Therapeutics, Inc. 10%+ Owner $5,202,170 23 Dec 2024
MTCR Metacrine, Inc. 10%+ Owner $1,204,731 10 Dec 2021
NEUE NeueHealth, Inc. Director, 10%+ Owner $0 -$1,890 -100% 02 Oct 2025
AKUS Akouos, Inc. 10%+ Owner 30 Nov 2022
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner 24 May 2022

Insider Transactions Reported by New Enterprise Associates 16, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.